Your browser doesn't support javascript.
loading
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study.
Acciarresi, Monica; Paciaroni, Maurizio; Agnelli, Giancarlo; Falocci, Nicola; Caso, Valeria; Becattini, Cecilia; Marcheselli, Simona; Rueckert, Christina; Pezzini, Alessandro; Morotti, Andrea; Costa, Paolo; Padovani, Alessandro; Csiba, Laszló; Szabó, Lilla; Sohn, Sung-Il; Tassinari, Tiziana; Abdul-Rahim, Azmil H; Michel, Patrik; Cordier, Maria; Vanacker, Peter; Remillard, Suzette; Alberti, Andrea; Venti, Michele; D'Amore, Cataldo; Scoditti, Umberto; Denti, Licia; Orlandi, Giovanni; Chiti, Alberto; Gialdini, Gino; Bovi, Paolo; Carletti, Monica; Rigatelli, Alberto; Putaala, Jukka; Tatlisumak, Turgut; Masotti, Luca; Lorenzini, Gianni; Tassi, Rossana; Guideri, Francesca; Martini, Giuseppe; Tsivgoulis, Georgios; Vadikolias, Kostantinos; Liantinioti, Chrissoula; Corea, Francesco; Del Sette, Massimo; Ageno, Walter; De Lodovici, Maria Luisa; Bono, Giorgio; Baldi, Antonio; D'Anna, Sebastiano; Sacco, Simona.
Afiliación
  • Acciarresi M; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy. Electronic address: macun77@hotmail.com.
  • Paciaroni M; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Agnelli G; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Falocci N; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Caso V; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Becattini C; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Marcheselli S; Neurologia d'urgenza e Stroke Unit, Istituto Clinico Humanitas, Rozzano, Milano, Italy.
  • Rueckert C; Abteilung für Neurologie, Oberschwabenklinik gGmbH, Ravensburg, Germany.
  • Pezzini A; Department of Clinical and Experimental Sciences, Neurology Unit, University "Health and Wealth" of Brescia, Brescia, Italy.
  • Morotti A; Department of Clinical and Experimental Sciences, Neurology Unit, University "Health and Wealth" of Brescia, Brescia, Italy.
  • Costa P; Department of Clinical and Experimental Sciences, Neurology Unit, University "Health and Wealth" of Brescia, Brescia, Italy.
  • Padovani A; Department of Clinical and Experimental Sciences, Neurology Unit, University "Health and Wealth" of Brescia, Brescia, Italy.
  • Csiba L; Stroke Unit, University of Debrecen, Debrecen, Hungary.
  • Szabó L; Stroke Unit, University of Debrecen, Debrecen, Hungary.
  • Sohn SI; Department of Neurology, Keimyung University School of Medicine, Daegu, South Korea.
  • Tassinari T; Stroke Unit-Department of Neurology, Santa Corona Hospital, Pietra Ligure, Savona, Italy.
  • Abdul-Rahim AH; Medical School and Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Michel P; Centre Cérébrovasculaire, Service de Neurologie, Département des Neurosciences Cliniques Centre Hopitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Cordier M; Centre Cérébrovasculaire, Service de Neurologie, Département des Neurosciences Cliniques Centre Hopitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Vanacker P; Department of Neurology, Born Bunge Institute, Antwerp University Hospital, Antwerp, Belgium.
  • Remillard S; Centre Cérébrovasculaire, Service de Neurologie, Département des Neurosciences Cliniques Centre Hopitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Alberti A; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Venti M; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • D'Amore C; Stroke Unit and Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
  • Scoditti U; Stroke Unit, Neuroscience Department, University of Parma, Parma, Italy.
  • Denti L; Stroke Unit, Dipartimento Geriatrico Riabilitativo, University of Parma, Parma, Italy.
  • Orlandi G; Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.
  • Chiti A; Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.
  • Gialdini G; Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.
  • Bovi P; SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI Verona, Italy.
  • Carletti M; SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI Verona, Italy.
  • Rigatelli A; SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI Verona, Italy.
  • Putaala J; Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
  • Tatlisumak T; Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Masotti L; Department of Internal Medicine, Cecina Hospital, Cecina, Livorno, Italy.
  • Lorenzini G; Department of Internal Medicine, Cecina Hospital, Cecina, Livorno, Italy.
  • Tassi R; Stroke Unit, AOU Senese, Siena, Italy.
  • Guideri F; Stroke Unit, AOU Senese, Siena, Italy.
  • Martini G; Stroke Unit, AOU Senese, Siena, Italy.
  • Tsivgoulis G; Department of Neurology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece; International Clinic Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic; Second Department of Neurology, "Attikon" Hospital, University of Athens, School
  • Vadikolias K; Department of Neurology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Liantinioti C; Second Department of Neurology, "Attikon" Hospital, University of Athens, School of Medicine, Athens, Greece.
  • Corea F; UO Gravi Cerebrolesioni, San Giovanni Battista Hospital, Foligno, Italy.
  • Del Sette M; Stroke Unit, Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy.
  • Ageno W; Department of Internal Medicine, Insubria University, Varese, Italy.
  • De Lodovici ML; Stroke Unit, Neurology, Insubria University, Varese, Italy.
  • Bono G; Stroke Unit, Neurology, Insubria University, Varese, Italy.
  • Baldi A; Stroke Unit, Ospedale di Portogruaro, Portogruaro, Venice, Italy.
  • D'Anna S; Stroke Unit, Ospedale di Portogruaro, Portogruaro, Venice, Italy.
  • Sacco S; Department of Neurology, University of L'Aquila, L'Aquila, Italy.
J Stroke Cerebrovasc Dis ; 26(6): 1363-1368, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28236595
ABSTRACT
BACKGROUND AND

PURPOSE:

The aim of this study was to investigate for a possible association between both prestroke CHA2DS2-VASc score and the severity of stroke at presentation, as well as disability and mortality at 90 days, in patients with acute stroke and atrial fibrillation (AF).

METHODS:

This prospective study enrolled consecutive patients with acute ischemic stroke, AF, and assessment of prestroke CHA2DS2-VASc score. Severity of stroke was assessed on admission using the National Institutes of Health Stroke Scale (NIHSS) score (severe stroke NIHSS ≥10). Disability and mortality at 90 days were assessed by the modified Rankin Scale (mRS <3 or ≥3). Multiple logistic regression was used to correlate prestroke CHA2DS2-VASc and severity of stroke, as well as disability and mortality at 90 days.

RESULTS:

Of the 1020 patients included in the analysis, 606 patients had an admission NIHSS score lower and 414 patients higher than 10. At 90 days, 510 patients had mRS ≥3. A linear correlation was found between the prestroke CHA2DS2-VASc score and severity of stroke (P = .001). On multivariate analysis, CHA2DS2-VASc score correlated with severity of stroke (P = .041) and adverse functional outcome (mRS ≥3) (P = .001). A logistic regression with the receiver operating characteristic graph procedure (C-statistics) evidenced an area under the curve of .60 (P = .0001) for severe stroke. Furthermore, a correlation was found between prestroke CHA2DS2-VASc score and lesion size.

CONCLUSIONS:

In patients with AF, in addition to the risk of stroke, a high CHA2DS2-VASc score was independently associated with both stroke severity at onset and disability and mortality at 90 days.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Técnicas de Apoyo para la Decisión / Accidente Cerebrovascular Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia / Europa Idioma: En Revista: J Stroke Cerebrovasc Dis Asunto de la revista: ANGIOLOGIA / CEREBRO Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Técnicas de Apoyo para la Decisión / Accidente Cerebrovascular Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia / Europa Idioma: En Revista: J Stroke Cerebrovasc Dis Asunto de la revista: ANGIOLOGIA / CEREBRO Año: 2017 Tipo del documento: Article
...